MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2025 International Congress
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Articles tagged "Dementia"

  • 2019 International Congress

    Severe hypomimia in drug naïve Parkinson´s disease patients may predict mild cognitive impairment

    C. Gasca-Salas, L. Vela, J. Obeso (Alcorcón, Spain)

    Objective: We aimed to analyze if hypomimia was associated with mild cognitive impairment in Parkinson´s disease  (PD-MCI) and if it predicted cognitive decline. Background: Hypomimia…
  • 2019 International Congress

    Cognitive impairment in patients with Parkinson’s Disease

    E. Kolupaeva, I. Zhukova, N. Zhukova, M. Nikitina, O. Izhboldina, I. Mironova, Z. Kislukhina (Tomsk, Russian Federation)

    Objective: The objective is to study the relation between cognitive impairment with the form and stage of PD. Background: Currently, there is a tendency of…
  • 2019 International Congress

    Clinical Response to 72-h Lumbar CSF Drainage in Idiopathic Normal Pressure Hydrocephalus associated with Parkinsonism: Timing and Correlates

    G. Mostile, G. Raudino, G. Portaro, F. Certo, A. Nicoletti, G. Barbagallo, M. Zappia (Catania, Italy)

    Objective: To evaluate timing and clinical correlates of motor response after 72-h lumbar CSF drainage in patients with Normal Pressure Hydrocephalus (iNPH) associated with parkinsonism.…
  • 2019 International Congress

    Self-report of cognitive functional abilities is inaccurate in PD-MCI and PDD

    S. Holden, L. Medina, A. Simpson, B. Kluger (Aurora, CO, USA)

    Objective: Evaluate concordance between self-reported and performance-based measures of cognitive functional abilities in PD by cognitive class. Background: PD-specific cognitive functional questionnaires, the Penn Daily…
  • 2019 International Congress

    Neuroanatomical correlates of early cognitive change in Parkinson’s disease

    E. Bunting, L-A. Leyland, R. Weil (London, United Kingdom)

    Objective: To identify the neuroanatomical basis of early cognitive change in Parkinson’s disease (PD). Background: 50% of PD patients develop dementia within 10 years of…
  • 2019 International Congress

    Parkinson Disease Clinical Subtypes Predict Dementia and Mortality Risk

    P. Myers, M. Campbell, A. Weigand, N. Cairns, J. Jackson, C. Lessov-Schlaggar, J. Perlmutter (St. Louis, MO, USA)

    Objective: To identify PD clinical subtypes based on patterns of motor, cognitive, and psychiatric symptoms; to assess the clinical utility of each subtype in predicting…
  • 2019 International Congress

    Neuropsychological changes over the first 6 years of Parkinson’s disease in the ICICLE-PD cohort

    R. Lawson, G. Duncan, T. Khoo, D. Breen, M. Camacho, C. Williams-Gray, R. Barker, L. Rochester, D. Burn, A. Yarnall (Newcastle Upon Tyne, United Kingdom)

    Objective: To determine the longitudinal differences in cognitive tests in participants with Parkinson’s disease (PD), and the neuropsychological tests most sensitive to change over and…
  • 2019 International Congress

    Dynamic functional connectivity signature of cognitive decline in Parkinson’s disease

    E. Fiorenzato, A. Strafella, J. Kim, R. Schifano, L. Weis, A. Antonini, R. Biundo (Venice, Italy)

    Objective: Aim of the present study was to characterize the dynamic changes of functional connectivity associated with Parkinson’s disease (PD) cognitive decline using dynamic functional…
  • 2019 International Congress

    Predictors of Retention for Carbidopa/Levodopa Intestinal Gel in Parkinson Disease

    A. Nagy, T. Davis, T. Hassell, P. Hedera, D. Isaacs, H. Koons, F. Phibbs, S. Afrow, J. Fang (Nashville, TN, USA)

    Objective: To identify predictors of discontinuation of levodopa/carbidopa intestinal gel therapy. Background: Although levodopa/carbidopa intestinal gel (LCIG) is an established treatment for Parkinson's disease complicated…
  • 2019 International Congress

    Using Brain Atrophy and Visual Dysfunction to Predict Dementia in Parkinson’s Disease

    L-A. Leyland, R. Mahmood, R. Weil (London, United Kingdom)

    Objective: To identify areas of regional volume loss in structural brain images relating to poorer visual function and risk of dementia in Parkinson’s Disease (PD).…
  • « Previous Page
  • 1
  • …
  • 18
  • 19
  • 20
  • 21
  • 22
  • …
  • 36
  • Next Page »

Most Viewed Abstracts

  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • “Magic carpet for freezing of gait ” Evaluating a combination of patterned and pictographic visual cues.
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley